Infoblox Inc Issues Q4 2013 Guidance; EPS Guidance Above Analy...

Cera Sanitaryware Limited, Ahmedabad based company has reported whopping top line of Rs. 487.87 Cr. for FY 2012-13, a growth of 52.75% over previous FY 2011-12 (Rs. 319.39 Cr.) Cera Sanitaryware Limited, Ahmedabad based company has reported whopping ...

* Toshiba sees op profit of $2.6 bln for 2013/14, up 34 pct * Logs Q4 operating profit of 96 bln yen vs 115 bln yen a year ago TOKYO, May 8 (Reuters) - Japan's Toshiba Corp forecast a 34 percent jump in operating profit for this fiscal year, boosted ...

(NASDAQ: NTCT): FY 2013 Q4 FY 2013 GAAP Non-GAAP GAAP Non-GAAP Revenue (in millions) $350.6 $351.8 $98.1 $98.6 Net income (in millions) $40.6 $56.0 $14.6 $18.1 Net income per share $0.96 $1.32 $0.34 $0.43 (NASDAQ: NTCT), an ...

5:00 PM ET Operator Good day, ladies and gentlemen, and welcome to ViaSat's FY 2013 Fourth Quarter Earnings Conference Call. Your host for today's call is Mark Dankberg, Chairman and CEO. You may proceed, Mr. Dankberg. Mark D. Dankberg Okay. Thanks.

Healthy Business Growth in a challenging environment. Q4 FY'12-13 12M FY'12-13 Total Business 17.5% Total Income Total Other Income Performance Highlights for the Q4 FY 2012-13 and 12M FY 2012-13 ended MARCH 2013 TOTAL BUSINESS • Total Business of ...

Mr S. L. Bansal (second from left) CMD, Oriental Bank of Commerce accompanied by EDs Mr V. Kannan & Mr Bhupinder Nayyar announcing the Annual Financial Results 2012 - 13 in New Delhi. Also seen in the picture is Mr C. M. Khurana, CFO of the Bank.

DOVER CORPORATION QUARTERLY EARNINGS PER SHARE (unaudited)(in thousands, except per share data*) 2013 2012 Q1 Q1 Q2 Q3 Q4 FY 2012 Basic earnings (loss) per common share: Continuing operations $ 1.14 $ 1.01 $ 1.12 $ 1.28 $ 1.17 $ 4.59 Discontinued ...

Coal India rose 1.25% to Rs 312 at 14:05 IST on BSE ahead of consolidated results for the year ended 31 March 2013 on Monday, 27 May 2013. Meanwhile, the BSE Sensex was up 60.26 points, or 0.31%, to 19,734.59. On BSE, 1.25 lakh shares were traded in ...

Israeli generic firm Taro's fourth quarter net profit grew by 4.2 percent year-on-year to USD 49.2 million and net sales rose by 13.8 percent Y-o-Y to USD 165.1 million during the quarter. Also Read - Wockhardt tanks 20% on US FDA import alert ...